Skip to Content

par C829 (Diltiazem Hydrochloride Extended-Release 120 mg)

Pill with imprint par C829 is Gray, Capsule-shape and has been identified as Diltiazem Hydrochloride Extended-Release 120 mg. It is supplied by Par Pharmaceutical, Inc..

Diltiazem is used in the treatment of atrial fibrillation; atrial flutter; heart failure; angina pectoris prophylaxis; high blood pressure and belongs to the drug classes calcium channel blocking agents, group IV antiarrhythmics. Risk cannot be ruled out during pregnancy. Diltiazem 120 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for par C829

Diltiazem hydrochloride extended-release 120 mg par C829

Diltiazem Hydrochloride Extended-Release

Imprint
par C829
Strength
120 mg
Color
Gray
Size
18.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Calcium channel blocking agents, Group IV antiarrhythmics
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Par Pharmaceutical, Inc.
Inactive Ingredients
ammonio methacrylate copolymer type A, ammonio methacrylate copolymer type B, ammonia, gelatin, hydroxypropyl cellulose (type l), propylene glycol, shellac, sodium lauryl sulfate, sucrose, magnesium silicate, titanium dioxide, triethyl citrate, ferrosoferric oxide, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
10370-0829 Anchen Pharmaceuticals, Inc.
63739-0283 McKesson Packaging Services
63739-0283 McKesson Packaging Services
42291-0184 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.